Susquehanna International Group’s CERo Therapeutics CERO Stock Holding History

Susquehanna International Group’s Portfolio CERO Stock Details CERO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,244	Closed	-$52.1K	–	13830
2025 Q3	$52.1K	Buy	+10,244	New	+$75.4K	﹤0.01%	11847
2025 Q2	–	Sell	-667	Closed	-$9.74K	–	13878
2025 Q1	$9.74K	Buy	+667	New	+$26.4K	﹤0.01%	12214
2023 Q2	–	Sell	-7	Closed	-$145K	–	13315
2023 Q1	$145K	Sell	7 -2	-22%	-$42.2K	﹤0.01%	10942
2022 Q4	$193K	Buy	+9	New	+$183K	﹤0.01%	10179

Susquehanna International Group's CERO Position: Q4 2025 in Review

Susquehanna International Group sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 10,244 shares — an estimated $52.1K sold.

Susquehanna International Group first reported a position in CERO in Q4 2022 and held it in 4 quarters. The position peaked at $193K in Q4 2022. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

Susquehanna International Group reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
Susquehanna International Group sold 10,244 CERo Therapeutics shares in Q4 2025, an estimated $52.1K.
Susquehanna International Group first reported a position in CERo Therapeutics in Q4 2022 and held it in 4 quarters.
Susquehanna International Group's CERo Therapeutics position peaked at $193K in Q4 2022.
0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.